Why publish your research with the International Journal of Neuropsychopharmacology?
International Journal of Neuropsychopharmacology (IJNP) is the official peer-reviewed, fully open access journal of the International College of Neuropsychopharmacology. IJNP provides a global and accessible forum for the publication of translational research into brain function and disease. It features the latest advances in understanding of existing and new neuropsychopharmacological agents including their clinical applications and provides insights into the biological basis of psychiatric disorders and their pharmacological treatment.
Read on to learn more about why the journal is the perfect home for your research.
Fully open access
International Journal of Neuropsychopharmacology prides itself in being a fully open access (OA) journal. Publishing OA offers several benefits for authors including:
- Increased visibility and accessibility: OA articles are freely available to anyone, removing any barriers to knowledge. This leads to increased readership and usage by a global audience, including researchers, students, policymakers, and the general public.
- Higher citation potential: OA articles tends to receive higher citation rates compared to articles published behind paywalls. This further boosts the impact and recognition of your work.
- Public engagement and societal impact: As mentioned above, publishing OA allows research to reach a broader audience beyond academic. This enables the ability for your research to have a potential impact on societal needs.
- Compliance with funding agency policies: Many funding agencies and institutions now require research outputs to be published OA, as it aligns with the principles of public funding and maximizing societal and science progress.
Oxford University Press has Read and Publish agreements with institutions and consortia which provide funding for open access publication. This means authors from participating institutions can publish open access, and the institution will pay the charge. Click here to see if your institution is participating.
Indexed in Web of Science, PubMed, Scopus & DOAJ
International Journal of Neuropsychopharmacology is proudly indexed in PubMed, Web of Science (SCI-E), Scopus and the Directory of Open Access Journals (DOAJ), which means your published work with the journal can benefit from increased discoverability, credibility and prestige, and enhanced research impact.
Key statistics
- Ranked in the top 25% (Q1) of journals in PSYCHIATRY, CLINICAL NEUROLOGY, and PHARMACOLOGY & PHARMACY in the Web of Science SCI-E
- Average monthly readership over 56,000
- Wide distribution of readers in Asia (17%), Europe (24%), and North America (43%)
- 4.5 Impact Factor
- Median 4 days from receipt in production to online publication (uncorrected proof)
- Average 37 days from submission to first decision
Rigorous peer review
Manuscripts submitted to IJNP including those for supplements are reviewed by at least two external reviewers and evaluated by a Field Editor. The journal operates single-anonymized peer review.
Ethical and trustworthy research
International Journal of Neuropsychopharmacology follows Committee on Publication Ethics (COPE) guidelines on ethical oversight. We take research integrity seriously, and all research published in the journal must have been conducted in a fair, trustworthy, and ethical manner.
Official journal of the International College of Neuropsychopharmacology
The International College of Neuropsychopharmacology (CINP - Collegium Internationale Neuro-Psychopharmacologicum) is a truly worldwide non-profit organization established over 60 years ago in Zurich, Switzerland. CINP is dedicated to promoting research and education worldwide—through regular meetings in form of trainings, educational programs, international meetings, and world congresses, CINP shares the latest research advances and new treatments with clinicians and researchers.
Published in partnership with Oxford University Press
As a department of the University of Oxford, OUP is a mission-driven, non-profit publisher committed to delivering world-class academic and educational resources and making them available as widely as possible. OUP understands the importance of making research accessible so that not only researchers, but also practitioners and policymakers around the world, are well-equipped with the latest information to better serve their communities.
Member discount on APCs
Corresponding authors who are members of The International College of Neuropsychopharmacology are eligible for an APC discount. Authors will be asked to prove eligibility for the member discount at the time of manuscript submission. See the open access section of the journal’s author guidelines for more information.
Ready to submit?
Please refer to our instructions to authors for more detailed information and manuscript requirements and our submission site if you are ready to submit. If you have any questions, please email the Editorial Office.
